Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Barker

Showing results (211-220 of 1,989) with videos related to

Pageof 199
Sort By:
Journal of Chromatography. A|July 11, 1997
Analysis of toxic wastes in tissues from aquatic species. Applications of matrix solid-phase dispersionM D Crouch, S A Barker
Annals of Surgical Oncology|June 4, 2026
Neoadjuvant PD-1 Blockade in Surgically Resectable Desmoplastic Melanoma: Cohort A of the Phase 2 SWOG S1512 TrialEdmund K Bartlett, Christopher A Barker
Expert Opinion on Pharmacotherapy|February 25, 2011
Defining meaningful outcome measures in trials of disease-modifying therapies in Parkinson's diseaseJonathan R Evans, Roger A Barker
Cell Stem Cell|August 5, 2010
Graft-induced dyskinesias in Parkinson's disease: what is it all about?Roger A Barker, Wei-Li Kuan
Seminars in Radiation Oncology|September 14, 2010
Enhancing radiotherapy through a greater understanding of homologous recombinationChristopher A Barker, Simon N Powell
The Canadian Veterinary Journal = La Revue Veterinaire Canadienne|April 3, 1998
The infancy of the CVMA: 1948-1967C A Barker, T A Crowley
Experimental Neurology|December 31, 2003
The potential of GDNF as a treatment for Parkinson's diseaseCarrie B Hurelbrink, Roger A Barker
Journal of Hematotherapy & Stem Cell Research|February 24, 2004
The future of cell-based transplantation therapies for neurodegenerative disordersStanley E Lazic, Roger A Barker
Expert Review of Neurotherapeutics|June 10, 2011
Cell-based therapies for Parkinson's diseaseSean C Dyson, Roger A Barker
Environmental Science & Technology|April 15, 2016
Implications of Transitioning from De Facto to Engineered Water Reuse for Power Plant CoolingZachary A Barker, Ashlynn S Stillwell
Pageof 199

Showing results (211-220 of 1,989) with videos related to

Sort By:
Pageof 199
Journal of Chromatography. A|July 11, 1997
Analysis of toxic wastes in tissues from aquatic species. Applications of matrix solid-phase dispersionM D Crouch, S A Barker
Annals of Surgical Oncology|June 4, 2026
Neoadjuvant PD-1 Blockade in Surgically Resectable Desmoplastic Melanoma: Cohort A of the Phase 2 SWOG S1512 TrialEdmund K Bartlett, Christopher A Barker
Expert Opinion on Pharmacotherapy|February 25, 2011
Defining meaningful outcome measures in trials of disease-modifying therapies in Parkinson's diseaseJonathan R Evans, Roger A Barker
Cell Stem Cell|August 5, 2010
Graft-induced dyskinesias in Parkinson's disease: what is it all about?Roger A Barker, Wei-Li Kuan
Seminars in Radiation Oncology|September 14, 2010
Enhancing radiotherapy through a greater understanding of homologous recombinationChristopher A Barker, Simon N Powell
The Canadian Veterinary Journal = La Revue Veterinaire Canadienne|April 3, 1998
The infancy of the CVMA: 1948-1967C A Barker, T A Crowley
Experimental Neurology|December 31, 2003
The potential of GDNF as a treatment for Parkinson's diseaseCarrie B Hurelbrink, Roger A Barker
Journal of Hematotherapy & Stem Cell Research|February 24, 2004
The future of cell-based transplantation therapies for neurodegenerative disordersStanley E Lazic, Roger A Barker
Expert Review of Neurotherapeutics|June 10, 2011
Cell-based therapies for Parkinson's diseaseSean C Dyson, Roger A Barker
Environmental Science & Technology|April 15, 2016
Implications of Transitioning from De Facto to Engineered Water Reuse for Power Plant CoolingZachary A Barker, Ashlynn S Stillwell
Pageof 199